Skip to main content
Premium Trial:

Request an Annual Quote

ABI and Invitrogen Join Forces on Labeling Reagents for Proteomics

NEW YORK, June 6 (GenomeWeb News) - Applied Biosystems and Invitrogen will co-market and re-sell their respective protein-labeling technologies for quantitative proteomics and biomarker studies, the companies said today.

 

Under the agreement, the companies will jointly sell ABI's iTRAQ and ICAT protein and peptide labeling reagents, and Invitrogen's new SILAC metabolomic labeling technology. ABI will also support Invitrogen's SILAC technology with software on its TOF/TOF mass spectrometers and plans to extend software support to other mass spec types.

 

In addition, the companies said they will co-develop and co-market protein sample preparation kits for mass spectrometry, as well as other reagents such as matrices, solubilizers, and calibrants.

 

Neither company disclosed financial terms of the agreement.

The Scan

More Boosters for US

Following US Food and Drug Administration authorization, the Centers for Disease Control and Prevention has endorsed booster doses of the Moderna and Johnson & Johnson SARS-CoV-2 vaccines, the Washington Post writes.

From a Pig

A genetically modified pig kidney was transplanted into a human without triggering an immune response, Reuters reports.

For Privacy's Sake

Wired reports that more US states are passing genetic privacy laws.

Science Paper on How Poaching Drove Evolution in African Elephants

In Science this week: poaching has led to the rapid evolution of tuskless African elephants.